Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences CellTech 2013

Stephen Minger's Biography

Stephen Minger, Global Director, GE Healthcare

Dr Stephen Minger was appointed the Global Director for Research and Development for Cell Technologies at GE Healthcare in September 2009. Stephen received his PhD in Pathology (Neurosciences) in 1992 from the Albert Einstein College of Medicine in New York City. After post-doctoral work in central nervous system gene therapy, neural transplantation and neural stem cell biology at UCSD with Professor Fred “Rusty” Gage, he moved to the UK in 1996 and was appointed a Lecturer in Biomolecular Sciences at King's College London in 1998. He was appointed a Senior Lecturer in Stem Cell Biology in 2005 and was the Director of the Stem Cell Biology Laboratory from 2002 until joining GE Healthcare in 2009. Stephen has recently been appointed Chief Scientist of Research and Applied Markets within GE Healthcare Life Sciences, where he is responsible for global scientific strategy.

Stephen Minger Image

Therapeutic & Research Potential of Human Stem Cells

Wednesday, 23 January 2013 at 09:00

Add to Calendar ▼

Cardiotoxicity and hepatotoxicity are common causes of drug safety issues and withdrawal of candidate drugs during development. The availability of more biologically relevant, i.e. human, predictive assays and cell models is key to improving the success rate in drug development and reducing the cost of drug discovery and development.

Add to Calendar ▼2013-01-22 00:00:002013-01-23 00:00:00Europe/LondonCellTech 2013CellTech 2013 in San Diego, CA, USASan Diego, CA,